Bryan Reasons compensation by year
Amneal Pharmaceuticals Summary Compensation Table · all 4 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Salary | $496,620 | $512,712 | $528,286 | $189,384 |
| Bonus | — | $0 | $0 | $0 |
| Stock awards | $868,780 | $217,593 | $499,998 | $0 |
| Option awards | $826,545 | $251,151 | $1,000,002 | $0 |
| Non-equity incentive | $0 | $283,119 | $298,616 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $56,579 | $49,459 | $37,369 | $1,662,095 |
| Total | $2,248,524 | $1,314,034 | $2,364,271 | $1,851,479 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amneal Pharmaceuticals, Inc. DEF 14A filed March 23, 2020, accession 0001308179-20-000070, and prior-year filings.
How this page was built: the Amneal Pharmaceuticals, Inc. filed document, accession 0001308179-20-000070. Every figure is read from that document and cited to the page and table it appears in. Filed March 23, 2020.
Amneal Pharmaceuticals’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Robert Stewart | Former President & CEO | $9,525,800 |
| Paul Bisaro | Former Executive Chairman | $4,119,314 |
| David Buchen | Former SVP, Chief Legal Officer | $3,651,747 |
| Pradeep Bhadauria | Former Chief Scientific Officer | $3,356,829 |
| Andrew Boyer | EVP, Commercial Operations | $3,113,079 |
| Todd Branning | Former SVP & CFO | $2,655,963 |
| Nikita Shah | EVP, CHRO & Strategic Planning Officer | $2,541,929 |
| Bryan Reasons · this page | Former SVP & CFO | $1,851,479 |
| Chintu Patel | Co-Chief Executive Officer | $339,600 |
| Chirag Patel | President & Co-Chief Executive Officer | $337,967 |
The full Amneal Pharmaceuticals compensation record
free company briefThis page is one person within Amneal Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Amneal Pharmaceuticals proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Amneal Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.